Lithium (Orotate) 1 mg 90c Pure Encapsulations

Lithium (Orotate) 1 mg 90c

Pure Encapsulations

$16.40
(No reviews yet) Write a Review
SKU:
PUR-P22901
Availability:
Usually Ships in 48 to 72 Hours
Already Registered?
How to Gain Access to Store?

Lithium (Orotate) 1 mg 90c by Pure Encapsulations

Lithium (Orotate) 1 mg 90c is a mood supplement by Pure Encapsulations.* Made with high-quality, vegan ingredients, this supplement may support mood and emotional wellness but also cognitive function and general neural health.*

Who May Take Lithium (Orotate) 1 mg 90c by Pure Encapsulations?

You may take Lithium (Orotate) 1 mg 90c if you:

  • suffer from major mood swings*
  • you were diagnosed with mania or hypomania*

How May Lithium (Orotate) 1 mg 90c Affect Your Health?

Lithium (Orotate) 1 mg 90c may:

  • support cognitive function*
  • promote mood stability*
  • support emotional and behavioral wellness*

Supplements support your health but do not replace a balanced diet. Always check with your healthcare professional if you have doubts about a new supplement. Do you need more information about Lithium (Orotate) 90c? Book a FREE product consultation with our medical advisors.

Recommendation:
Pure Encapsulations suggests taking 1 capsule daily, with a meal, or as directed by a health professional.

Serving Size: 1 capsule
Servings Per Container: 90

Amount Per Serving:
Lithium (as lithium orotate)1 mg

Other Ingredients: hypoallergenic plant fiber (cellulose), vegetarian capsule (cellulose, water)

Caution: Not to be taken by pregnant and lactating women. Consult your health professional before using this product. Not to be taken in conjunction with antidepressants unless advised by a health professional. Individuals with bipolar disorder and depression must be monitored closely by a health professional if taking this supplement. It is recommended that individuals taking this supplement have lithium levels and kidney function monitored regularly. Do not exceed the dose recommended by your health professional.

Storage: Store in a cool, dry place.

*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Pure Encapsulations logo, text, graphics, and photo images are the property of Société des Produits Nestlé S.A. and are used with permission. Copyright © 2021.

Click here to view Product Info Sheet

References:

  1. Beaulieu, J. M., Zhang, X., Rodriguiz, R. M., Sotnikova, T. D., Cools, M. J., Wetsel, W. C., & Caron, M. G. (2004). Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proceedings of the National Academy of Sciences, 101(14), 5099-5104. https://doi.org/10.1073/pnas.0306667101
  2. Forlenza, O. V., Diniz, B. S., Radanovic, M., Santos, F. S., Talib, L. L., & Gattaz, W. F. (2011). Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: Randomized controlled trial. British Journal of Psychiatry, 198(5), 351-356. https://doi.org/10.1192/bjp.bp.110.080044
  3. Leyhe, T., Stransky, E., Eschweiler, G. W., & Buchkremer, G. (2009). Increase of BDNF serum concentration in lithium treated patients with early Alzheimer’s disease. Journal of Alzheimer's Disease, 16(3), 649-656. https://doi.org/10.3233/JAD-2009-0979
  4. Nunes, M. A., Viel, T. A., & Buck, H. S. (2013). Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease. Current Alzheimer Research, 10(1), 104-107. https://doi.org/10.2174/156720501131001011
  5. Schrauzer, G. N., & Shrestha, K. P. (1994). Lithium in drinking water and the incidences of crimes, suicides, and arrests related to drug addictions. Biological Trace Element Research, 40(1), 89-101. https://doi.org/10.1007/BF02917573
  6. Shao, L., Young, L. T., & Wang, J. F. (2008). Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Neuroscience, 151(2), 518-524. https://doi.org/10.1016/j.neuroscience.2007.10.026
  7. Straten, G., Scapozza, L., Oertli, K., & Taschner, G. (2011). Acetylcholinesterase inhibitors and psychotropic drugs in the treatment of Alzheimer's disease: Effects on behavioral disturbances. Current Alzheimer Research, 8(8), 853-859. https://doi.org/10.2174/156720511798192915
  8. Szklarska, D., & Rzymski, P. (2019). Is lithium a micronutrient? From biological activity and epidemiological observation to food fortification. Biological Trace Element Research, 189(1), 18-27. https://doi.org/10.1007/s12011-018-1612-x